Announced Wed, 22 Jul · 15:10 IST
USFDA inspection at Tanuku facility ends with 6 observations in Form 483
Regulatory & Legal View source PDF
WANBURY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.5%1-day move
₹341.00
prior close
₹327.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4+0.1+0.7—-3.5-2.6-3.7———————
Up moveDown movePending
AI summary
USFDA completed a routine cGMP inspection at Wanbury's Tanuku facility in Andhra Pradesh from July 13 to July 17, 2026. The inspection ended with a Form 483 containing six observations. The company will respond within the stipulated time and says all observations are addressable. Wanbury expects no impact on manufacturing, US exports, or financial performance.
Likely market impact
Form 483 observations are typically addressable; company expects no material impact on operations or finances, though USFDA follow-up remains a watch point.